Anti-Human IL17A Therapeutic Antibody (Secukinumab)
Recombinant monoclonal antibody to IL17A. Secukinumab is a human monoclonal antibody designed for the treatments of uveitis, rheumatoid arthritis, and psoriasis. It targets member A from the cytokine family of interleukin 17.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-069 |
Pricing | Inquiry |
Host | Human |
Target | IL17A |
Species Reactivity | Human |
Type | IgG1 - kappa |
Applications | IF, IHC, ELISA, FC |
Storage | At -20°C for one year. |